Think AHEAD of Alzheimer's Disease

Join a new Alzheimer’s prevention trial funded by NIH and Eisai Inc. testing an investigational treatment aimed at delaying memory decline in people before the symptoms of Alzheimer’s disease are apparent.

Doctor and senior citizen

The AHEAD Study is an exciting, new development in Alzheimer’s disease research.

The AHEAD Study tests whether an investigational treatment slows the earliest brain changes associated with Alzheimer’s disease.

Brain changes related to Alzheimer’s disease can begin up to 20 years before a person exhibits symptoms.

Discovering a treatment that targets these changes early, means we may be able to some day prevent memory loss. The AHEAD Study tests whether an investigational treatment slows the earliest brain changes associated with Alzheimer’s disease.

Some participants will take part in the first pre-preclinical Alzheimer’s disease trial, representing a big step forward in Alzheimer’s disease research.

The AHEAD Study is breaking new ground in the field of Alzheimer’s research.

The AHEAD Study seeks cognitively normal adults ages 55-80 who may be at increased risk of memory loss associated with Alzheimer’s disease. This is the first Alzheimer’s disease prevention trial to enroll people as young as 55 years old.

Participants receive $50 per visit as compensation for their time.

Take the pre-screener to see if you are eligible to participate in the AHEAD Study.

Why Participate?

There are many reasons to partner with the AHEAD Study researchers and join the fight against Alzheimer’s disease.

Think AHEAD of Alzheimer’s Disease

Participating in this research will help our understanding of how Alzheimer’s disease develops in the brain before symptoms appear, and hopefully contribute to finding a treatment to one day prevent memory loss due to Alzheimer’s disease.

Contribute to Groundbreaking Research

Participants in this study will work closely with world-renowned academic researchers. You can help scientists learn about Alzheimer’s disease and develop solutions, while learning about your own health and risks for Alzheimer’s disease.

Help Your Community

Alzheimer’s disease affects everyone, everywhere. People of every race and ethnicity are needed for this study. Some communities, such as African American/Black and Latino/a individuals, may be at higher risk for Alzheimer’s disease, but are underrepresented in research. Diverse participation is essential to understanding and finding preventions for Alzheimer’s disease in everyone. Help find answers that benefit your community by participating in the AHEAD Study.

Note: Due to COVID-19, all in-person visits are conducted with special safety precautions to reduce person-to-person contact.

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et

Play Video

Latest News

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua